No cerebral vascular anomaly before and after treatment observed - Successful completion of the FIM II clinical study prior to the pivotal study, that will pave the way for CE marking Cardiawave SA
The trial with VALVOSOFT its disruptive, non-invasive, ultrasound treatment was proven to: be safe and feasible provide a sustained repair of the aortic valve improve quality of life